. . . . . . . "[We have previously shown in CD4 T cells that IL7R? haplotypes 1 and 2, but not 4, respond to interferon beta (IFN?), the most commonly used immunomodulatory drug in MS, and that haplotype 4 (Hap 4) homozygotes have the highest risk of developing MS. We now show that IL7R expression increases in myeloid cells in response to IFN?, but that the response is haplotype-dependent, with cells from homozygotes for Hap 4 again showing no response.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:13:52+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .